You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
BlueBox- a complete code blue data recorder
SBC: NeoVative, Inc. Topic: 400DESCRIPTION provided by applicant andquot Code blue andquot the term used in hospitals to call for an immediate cardiopulmonary resuscitation CPR signals dire emergencies where medical errors can occur and lives can be lost Reviewing CPR performance of the code blue team is a cornerstone for improving outcomes Thorough and accurate recording of code blue events enable detailed reviews to ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Asthmagram: objective assessment of asthma symptoms in children
SBC: NeoVative, Inc. Topic: NHLBIDESCRIPTION provided by applicant Asthma is the most common chronic illness of childhood but many children have poorly controlled symptoms causing morbidities hospitalizations and costs The first step toward good asthma control is accurate assessment of symptoms Recall of the frequency and severity of symptoms is the cornerstone of asthma assessment Unfortunately recall by parents or ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Identification of patients with diabetes at high risk for treatment failure
SBC: LP INFORMATION TECHNOLOGY INC. Topic: 200DESCRIPTION provided by applicant The overall goal of this project is to improve quality of care of patients with diabetes by identifying patients who may have particular difficulty reaching treatment targets and who could therefore potentially benefit from additional resources Investigators propose to achieve this goal by developing a technology to accurately identify patients at high risk f ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
A Structural Brain MRI Dementia Forecast Tool
SBC: CORTICOMETRICS LLC Topic: NIADESCRIPTION provided by applicant Alzheimerandapos s disease AD the most common type of dementia is a devastating disease with no available treatment or prevention The current lifetime risk for a year old individual is estimated to be around Given current projections over million individuals will be diagnosed with Alzheimerandapos s disease by As the development of the ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Improved Performance of Neonatal Vascular Access Catheters via 3D Magnetic Printing
SBC: N2 Biomedical, LLC Topic: NICHDDESCRIPTION provided by applicant Clinical treatment of infants in the neonatal intensive care unit NICU is particularly challenging due to their small anatomies medical instability and immature physiological processes Treatment is often complicated by the lack of therapeutic devices and instrumentation designed specifically to accommodate this unique patient population For instance curr ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Utilization of cord blood-expanded stem cells for megakaryocyte and platelet production
SBC: AllCells, LLC Topic: NHLBIDESCRIPTION provided by applicant Platelet transfusions are the most effective treatments for patients with thrombocytopenia The growing demand for platelet transfusions is often limited by shortage in the platelets PTL supply due to dependency on volunteer donors short shelf life risk of infections and alloimmunization It is therefore critical to create an efficient donor independent ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Investigation of a nanoparticle albumin-bound mTOR inhibitor, nab-rapamycin for t
SBC: AADI, LLC Topic: 102DESCRIPTION provided by applicant In it is estimated that there will be new bladder cancer cases in the United States resulting in deaths Most cases present with nonmuscle invasive bladder cancer NMIBC Intravesical bacillus Calmette Guerin BCG which elicits a nonspecific local immune response is considered the standard first line treatment However ...
STTR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
Development and testing of a behavioral activation mobile therapy for elevated depressive symptoms
SBC: MOUNTAINPASS TECHNOLOGY LLC Topic: 104DESCRIPTION provided by applicant Approximately of the population experiences elevated depressive symptoms Kubik et al Despite recent research suggesting that overall population mortality would be reduced by if the effects of subthreshold depression could be blocked completely the majority of individuals with elevated depressive symptoms never receive evidence based treat ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Dysbiotic Rebalancing with S. epidermidis Fermentation in Acne Vulgaris
SBC: Surface Bioadvances, Inc. Topic: NIAMSDESCRIPTION provided by applicant Dysbiosis refers to a condition with microbial imbalances within the human microbiome Yogurts are the best examples of using fermenting gut bacteria to rebalance the gut dysbiosis Our results demonstrate for the first time that Staphylococcus epidermidis S epidermidis a commensal bacterium of the human skin functions as a probiotic microorganism that em ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Novel Activin A Antagonists for Treatment of Osteoporosis
SBC: ABREOS BIOSCIENCES, INC. Topic: NIAMSDESCRIPTION provided by applicant Bone loss and fragility from osteoporosis afflict more than million people worldwide including at least million Americans Current osteoporosis treatments are significantly deficient most fail to reverse bone loss and or have adverse effects that prohibit their long term use New therapeutic approaches are urgently needed Recently the TGF family li ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health